Here’s whether Oric Pharmaceuticals, Inc. Common Stock (ORIC) is worth buying in 2026 —
based on weekly-updated price trend, RSI momentum, and return vs.
the S&P 500. Our current read: Bullish.
🟢
Bullish
Positives: trading above the 200-day MA (long-term uptrend intact); above the 50-day MA (medium-term momentum positive); 50-day MA is rising (+3.45% over 10 days); 3-month momentum positive (+18.2%). Currently 19.0% off its 52-week high. Score: +5/7.
ORIC is in a confirmed uptrend, trading above both its 50-day ($9.32) and 200-day ($10.64) moving averages. An RSI of 65.6 sits in the neutral zone — momentum is neither stretched nor exhausted. The 1-year return of +3.1% compares to +16.5% for SPY (trailed the market by 13.3%).
$10,000 invested 1 year ago→ $10,315 today
vs. S&P 500 (SPY) — same period trailed market by 13.3%
1-Year Price Chart
Daily candles
MA-50MA-200UpDown
Signal Check
✓Above 200-day MA ($10.64)
✓Above 50-day MA ($9.32)
✓RSI(14) neutral zone (30–70) — currently 65.6
✓Positive return (+3.1%)
!Within 10% of period high (−19.0%)
Period Range $12.10
$7.23$14.93
RSI (14) 65.6
0 · OversoldOverbought · 100
Key Metrics
Price$12.10
Period Return+3.1%
Period High$14.93
Period Low$7.23
Drawdown−19.0%
MA-50$9.32
MA-200$10.64
RSI (14)65.6
Avg Volume (30d)1.7M
vs. SPYtrailed by 13.3%
Return Rank#491 of 999
Trend Signals
Price is above the 200-day moving average ($10.64)